期刊文献+

葛根素降低ApoE-/-小鼠visfatin表达抑制动脉粥样硬化形成的研究 被引量:6

Study of Puerarin on Inhibiting the Progression of Atherosclerosis by Down-regulating Visfatin Expression in Apo E Knockout Mice
原文传递
导出
摘要 目的观察葛根素对载脂蛋白E基因敲除(Apo E-/-)小鼠主动脉粥样硬化(AS)病变、血脂水平、内脏脂肪素(visfatin)及炎症因子IL-6及TNF-α表达的影响。方法 50只SPF级8周龄雄性Apo E-/-小鼠予高脂饲料喂养随机分为5组:葛根素低、中、高剂量组分别给予葛根素300,600,1200 mg·kg-1·d-1灌胃;辛伐他汀组灌服辛伐他汀5 mg·kg-1·d-1;模型组灌服等剂量生理盐水。另设10只相同基因背景和周龄的雄性C57BL/6J小鼠为对照组予普通饲料喂养。16周后测小鼠体质量、血清脂质及visfatin、血浆IL-6及TNF-α含量;HE染色观察小鼠主动脉组织AS斑块面积;western blotting测小鼠主动脉visfatin蛋白的表达。结果各给药组小鼠体质量增加值、血清visfatin、TG、TC、LDL-C水平、血浆IL-6及TNF-α含量、主动脉visfatin蛋白表达均显著低于模型组(P<0.05),血清HDL-C高于模型组(P<0.05);辛伐他汀组、葛根素中、高剂量组小鼠主动脉AS斑块面积百分比显著低于模型组(P<0.05)。结论葛根素可通过降血脂、减小AS斑块面积、降低IL-6及TNF-α含量等发挥抗AS效应,其机制可能与降低visfatin表达有关。 Objective To study the effect of puerarin on serum lipids concentrations,atherosclerotic plaque area quantification at aorta,the circulating levels of serum visfatin and plasma inflammatory cytokines IL- 6 and TNF- α,and visfatin expression in the aorta of Apo E knockout( Apo E- /-) mice. Methods Fifty male 8- week- old Apo E- /-mice were fed with a western diet( 21%fat and 0. 15% cholesterol) for 16 weeks to establish atherosclerosis model and randomly assigned into five groups: model group,low- dose puerarin( 300 mg·kg- 1·d- 1) group,medium- dose puerarin( 600 mg·kg- 1·d- 1) group,high- dose puerarin( 1200 mg·kg- 1·d- 1) group and simvastatin( 5 mg·kg- 1·d- 1) group. Ten C57BL/6J mice fed with a common diet were served as control group. All mice were sacrificed after 16 weeks,serum concentrations of TC,TG,HDL- C,and LDL- C were determined by enzymatic procedures. The circulating levels of serum visfatin,plasma IL- 6 and TNF- α were analyzed using an ELISA method. Atherosclerotic lesions in the aortic root were examined by H E staining. Visfatin expression in the aorta was identified by western blotting. Results The add weight value,serum visfatin,TG,TC and LDL- C,plasma IL- 6 and TNF- α,visfatin expression in the aorta of each treatment group were statistically decreased compared with model group( P〈0. 05 or P〈0. 01),while serum HDL- C levels in control group,simvastatin group,high- dose puerarin group and medium- dose puerarin group were higher than that of model group( P〈0. 05 or P〈0. 01). Atherosclerotic lesions in the aortic root of simvastatin group,high- dose puerarin group and medium- dose puerarin group were statistically decreased compared with model group( P〈0. 01).Conclusion Puerarin can inhibit the progression of atherosclerosis by reducing serum lipids concentrations,atherosclerotic lesions in mice aorta,plasma IL- 6 and TNF- α levels in Apo E- /-mice,the mechanism is related to down- regulating visfatin expression.
出处 《时珍国医国药》 CAS CSCD 北大核心 2015年第6期1305-1308,共4页 Lishizhen Medicine and Materia Medica Research
基金 国家自然科学基金(No.81373574 No.81460680) 江西省科技计划项目(No.201355BBG70002) 广州市海珠区科技计划项目(No.2013-cg-35)
关键词 葛根素 动脉粥样硬化 内脏脂肪素 白细胞介素-6 肿瘤坏死因子-α Puerarin Atherosclerosis Visfatin Interleukin-6 Tumor necrosis factor-α
  • 相关文献

参考文献19

  • 1Chen Z, Martin M, Li Z,et al. Endothelial dysfimction :the role of sterol regulatory element - binding prtein - induced NOD - like receptor l.m- ily pyrin domain- containing protein 3 inflammasome in atherosclerosis [ J ]. Curr Opin Lipido1,2014,25 ( 5 ) :339.
  • 2Fukuhara A, Matsuda M, Nishizawa M, et al. Visfatin : a protein secreted by visceral fat that mimics the effects of insulin[ J]. Seience,2005,307 (5708) :426.
  • 3Filippatos T D,Tsimihodimos V, Derdemezis C S, et al. Increased plas- ma visfatin concentration is a marker of an atherogenic metabolic profile [J]. Nutr Metab Cardiovasc Dis,2013,23(4) :330.
  • 4Mu J,Feng B,Ye Z,et al. Visfatin is related to lipid dysregulaticm,en- dothelial d.sfunction amt atherc)selerosis in patients with chromic kidne','disease[J].JNephrol,2011,24(2):177.
  • 5魏群,陈芳,沈晓君,魏宴.葛根素对兔动脉粥样硬化炎症因子的影响[J].中国老年学杂志,2011,31(18):3541-3543. 被引量:15
  • 6魏晏,沈晓君.葛根素对动脉粥样硬化兔平滑肌细胞核因子-κB表达的影响[J].新中医,2010,42(4):89-90. 被引量:10
  • 7Cantarini L, Brueato A, Simonini G, et al. Leptin, adiponeetin, resistin, visfatin serum levels and idiopathic recurrent pericarditis:biomarkers of disease activity'?. A preliminary report[ J ]. Clin Exp Rheumatol,2013, 31 (2) :207.
  • 8Kong Q X, Xia M, Liang R Q, et al. Increased serum visfatin as a risk factor for atherosclerosis in patients with ischaemic cerebruvascular dis- ease[ J]. Singapore Med J,2014,55 (7) :383.
  • 9Dahl T B, Yndestad A, Skjelland M, et al. Increased expression of visfa- tin in macrophages of human unstable carotid and coronary atherosclero- sis:possible role in inflammation and plaque destabilization [ J 1- Circu- lation ,2007,115 ( 8 ) :972.
  • 10Zhang S H, Reddick R L,Piedrahita J A, et al. Spontaneous hyperchol- esterolemia and arterial lesions in mice lacking apolipoprotein E [ J ]. Science, 1992,258 ( 5081 ) :468.

二级参考文献38

共引文献51

同被引文献73

引证文献6

二级引证文献113

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部